Structure-activity studies reveal scope for optimisation of Ebselen-type inhibition of SARS-COV-2 main protease
<p>The reactive organoselenium compound ebselen is being investigated for treatment of coronavirus disease 2019 (COVID-19) and other diseases. We report structure-activity studies on sulfur analogues of ebselen with the Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) main protease...
主要な著者: | , , , , , , , |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Wiley
2021
|